BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bussio JI, Molina-Perea C, González-Aramundiz JV. Hyaluronic Acid Nanocapsules as a Platform for Needle-Free Vaccination. Pharmaceutics 2019;11:E246. [PMID: 31130688 DOI: 10.3390/pharmaceutics11050246] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Grego EA, Siddoway AC, Uz M, Liu L, Christiansen JC, Ross KA, Kelly SM, Mallapragada SK, Wannemuehler MJ, Narasimhan B. Polymeric Nanoparticle-Based Vaccine Adjuvants and Delivery Vehicles. Curr Top Microbiol Immunol 2021;433:29-76. [PMID: 33165869 DOI: 10.1007/82_2020_226] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Li M, Kaminskas LM, Marasini N. Recent advances in nano/microparticle-based oral vaccines. J Pharm Investig 2021;:1-14. [PMID: 34150345 DOI: 10.1007/s40005-021-00537-9] [Reference Citation Analysis]
3 Long L, Zhang J, Yang Z, Guo Y, Hu X, Wang Y. Transdermal delivery of peptide and protein drugs: Strategies, advantages and disadvantages. Journal of Drug Delivery Science and Technology 2020;60:102007. [DOI: 10.1016/j.jddst.2020.102007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
4 Zeng Y, Xiang Y, Sheng R, Tomás H, Rodrigues J, Gu Z, Zhang H, Gong Q, Luo K. Polysaccharide-based nanomedicines for cancer immunotherapy: A review. Bioactive Materials 2021;6:3358-82. [DOI: 10.1016/j.bioactmat.2021.03.008] [Reference Citation Analysis]
5 Kumar M, Dogra R, Mandal UK. Nanomaterial-based delivery of vaccine through nasal route: Opportunities, challenges, advantages, and limitations. Journal of Drug Delivery Science and Technology 2022;74:103533. [DOI: 10.1016/j.jddst.2022.103533] [Reference Citation Analysis]
6 Valdivia-Olivares RY, Rodriguez-Fernandez M, Álvarez-Figueroa MJ, Kalergis AM, González-Aramundiz JV. The Importance of Nanocarrier Design and Composition for an Efficient Nanoparticle-Mediated Transdermal Vaccination. Vaccines (Basel) 2021;9:1420. [PMID: 34960166 DOI: 10.3390/vaccines9121420] [Reference Citation Analysis]
7 Sallam MA, Prakash S, Kumbhojkar N, Shields CW 4th, Mitragotri S. Formulation-based approaches for dermal delivery of vaccines and therapeutic nucleic acids: Recent advances and future perspectives. Bioeng Transl Med 2021;6:e10215. [PMID: 34589595 DOI: 10.1002/btm2.10215] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Lee S, Woo C, Ki CS. Pectin nanogel formation via thiol-norbornene photo-click chemistry for transcutaneous antigen delivery. Journal of Industrial and Engineering Chemistry 2022. [DOI: 10.1016/j.jiec.2021.12.038] [Reference Citation Analysis]
9 Luzuriaga MA, Shahrivarkevishahi A, Herbert FC, Wijesundara YH, Gassensmith JJ. Biomaterials and nanomaterials for sustained release vaccine delivery. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2021;:e1735. [PMID: 34180608 DOI: 10.1002/wnan.1735] [Reference Citation Analysis]
10 Kim H, Lee S, Ki CS. Modular formation of hyaluronic acid/β-glucan hybrid nanogels for topical dermal delivery targeting skin dendritic cells. Carbohydrate Polymers 2021;252:117132. [DOI: 10.1016/j.carbpol.2020.117132] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
11 Trimzi MA, Ham YB. A Needle-Free Jet Injection System for Controlled Release and Repeated Biopharmaceutical Delivery. Pharmaceutics 2021;13:1770. [PMID: 34834185 DOI: 10.3390/pharmaceutics13111770] [Reference Citation Analysis]
12 Bashiri S, Koirala P, Toth I, Skwarczynski M. Carbohydrate Immune Adjuvants in Subunit Vaccines. Pharmaceutics 2020;12:E965. [PMID: 33066594 DOI: 10.3390/pharmaceutics12100965] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]